EARLY HCV VIRAL KINETICS UNDER DAAs MAY OPTIMIZE DURATION OF THERAPY IN PATIENTS WITH COMPENSATED CIRRHOSIS

BACKGROUND AND AIMS: Detailed hepatitis C virus (HCV) kinetics modeling is scarce in patients with advanced liver disease receiving direct-acting antivirals (DAAs). Due to budget restrictions, patients and health systems would benefit from the shortest possible treatment course. We investigated whet...

Full description

Saved in:
Bibliographic Details
Published in:Liver Int
Main Authors: Gambato, Martina, Canini, Laetitia, Lens, Sabela, Graw, Frederik, Perpiñan, Elena, Londoño, Maria-Carlota, Uprichard, Susan L., Mariño, Zoe, Reverter, Enric, Bartres, Concepcio, González, Patricia, Pla, Anna, Costa, Josep, Burra, Patrizia, Cotler, Scott J., Forns, Xavier, Dahari, Harel
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483833/
https://ncbi.nlm.nih.gov/pubmed/30499631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14014
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items